Patent: 9,550,997
✉ Email this page to a colleague
Summary for Patent: 9,550,997
Title: | Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
Abstract: | The present invention relates techniques for identifying suitable secretion fusion partner (SFP) for hyper-secretory production of recombinant proteins. The SFPs can be obtained from secretome analyzes. Recombinant proteins are produced in a fusion form with a secretion fusion partner (SFP) and can be separated from the SFP by in vitro protease treatment. SFPs of this invention greatly improve the secretion level of target proteins and peptides which are valuable for bio-pharmaceuticals and the bio-industry. |
Inventor(s): | Sohn; Jung-Hoon (Chungbuk, KR), Bae; Jung-Hoon (Daejeon, KR), Kim; Hyun-Jin (Ulsan, KR), Lim; Kwang-Mook (Daejeon, KR) |
Assignee: | Korean Research Institute of Bioscience and Biotechnology (Daejeon, KR) |
Application Number: | 12/631,449 |
Patent Claims: | see list of patent claims |
Details for Patent 9,550,997
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2028-12-04 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2028-12-04 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2028-12-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |